📣 VC round data is live. Check it out!
- Public Comps
- Promimic
Promimic Valuation Multiples
Discover revenue and EBITDA valuation multiples for Promimic and similar public comparables like Modular Medical, Polyrizon, European Medical Solutions, EVION Group and more.
Promimic Overview
About Promimic
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.
Founded
2004
HQ

Employees
N/A
Website
Financials (FY)
EV
$24M
Valuation Multiples
Start free trialPromimic Financials
Promimic reported last fiscal year revenue of $5M and negative EBITDA of ($211K).
In the same fiscal year, Promimic generated $5M in gross profit, ($211K) in EBITDA losses, and had net loss of ($941K).
Promimic P&L
In the most recent fiscal year, Promimic reported revenue of $5M and EBITDA of ($211K).
Promimic is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (4%), and net margin of (20%).
Financial data powered by Morningstar, Inc.
Promimic Stock Performance
Promimic has current market cap of $26M, and enterprise value of $24M.
Market Cap Evolution
Promimic's stock price is $1.38.
Promimic share price decreased by 12.5% in the last 30 days, and by 29.1% in the last year.
Promimic has an EPS (earnings per share) of $-0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $24M | $26M | -11.8% | -12.5% | -8.5% | -29.1% | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPromimic Valuation Multiples
Promimic trades at 5.0x EV/Revenue multiple, and (112.5x) EV/EBITDA.
Promimic Financial Valuation Multiples
As of June 3, 2026, Promimic has market cap of $26M and EV of $24M.
Promimic has a P/E ratio of (27.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Promimic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Promimic Margins & Growth Rates
In the most recent fiscal year, Promimic reported gross margin of 100%, EBITDA margin of (4%), and net margin of (20%).
Promimic Margins
Promimic Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Promimic Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Promimic Competitors
Promimic competitors include Modular Medical, Polyrizon, European Medical Solutions, EVION Group, NanoRepro, IMD International Medical, CS Diagnostics, Egide, Medclair and Nova Eye Medical.
Most Promimic public comparables operate across Advanced Materials, Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | (1.3x) | - | |||
| - | - | (4.9x) | - | |||
| 0.7x | - | 7.3x | - | |||
| - | - | - | - | |||
| 3.5x | 1.0x | (4.7x) | (14.9x) | |||
| 0.4x | - | 5.8x | - | |||
| - | - | - | - | |||
| 0.8x | - | (104.0x) | - | |||
This data is available for Pro users. Sign up to see all Promimic competitors and their valuation data. Start Free Trial | ||||||
Promimic VC Funding History
Before going public, Promimic raised $7M in total equity funding, across 3 rounds.
Promimic Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Promimic
| When was Promimic founded? | Promimic was founded in 2004. |
| Where is Promimic headquartered? | Promimic is headquartered in Sweden. |
| Is Promimic publicly listed? | Yes, Promimic is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Promimic? | Promimic trades under PRO ticker. |
| When did Promimic go public? | Promimic went public in 2022. |
| Who are competitors of Promimic? | Promimic main competitors include Modular Medical, Polyrizon, European Medical Solutions, EVION Group, NanoRepro, IMD International Medical, CS Diagnostics, Egide, Medclair, Nova Eye Medical. |
| What is the current market cap of Promimic? | Promimic's current market cap is $26M. |
| What is the current revenue of Promimic? | Promimic's last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of Promimic? | Current revenue multiple of Promimic is 5.0x. |
| Is Promimic profitable? | No, Promimic is not profitable. |
| How many companies Promimic has acquired to date? | Promimic hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Promimic has invested to date? | Promimic hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Promimic
Lists including Promimic
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.